Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors

Cancer ◽

10.1002/(sici)1097-0142(19991201)86:11<2406::aid-cncr31>3.0.co;2-e ◽

1999 ◽

Vol 86 (11) ◽

pp. 2406-2412 ◽

Author(s):

Taina A. Partanen ◽

Kari Alitalo ◽

Markku Miettinen

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Growth Factor Receptor ◽

Vascular Tumors ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Download Full-text

Vascular Endothelial Growth Factor Receptor 2 as a Marker for Malignant Vascular Tumors and Mesothelioma

The American Journal of Surgical Pathology ◽

10.1097/pas.0b013e318243555b ◽

2012 ◽

Vol 36 (4) ◽

pp. 629-639 ◽

Author(s):

Markku Miettinen ◽

Maarit-Sarlomo Rikala ◽

Janusz Rys ◽

Jerzy Lasota ◽

Zeng-Feng Wang

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Growth Factor Receptor ◽

Vascular Tumors ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Download Full-text

Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3): A Marker of Vascular Tumors with Presumed Lymphatic Differentiation, Including Kaposi's Sarcoma, Kaposiform and Dabska-Type Hemangioendotheliomas, and a Subset of Angiosarcomas

Modern Pathology ◽

10.1038/modpathol.3880033 ◽

2000 ◽

Vol 13 (2) ◽

pp. 180-185 ◽

Author(s):

Andrew L Folpe ◽

Tanja Veikkola ◽

Reija Valtola ◽

Sharon W Weiss

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Kaposi's Sarcoma ◽

Growth Factor Receptor ◽

Kaposi’S Sarcoma ◽

Vascular Tumors ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Download Full-text

Fortgeschrittenes medulläres Schilddrüsenkarzinom: Vandetanib verbessert das progressionsfreie Überleben

Onkologische Welt ◽

10.1055/s-0038-1631032 ◽

2012 ◽

Vol 03 (02) ◽

pp. 93-92

Author(s):

Alexander Kretzschmar

Keyword(s):

Vascular Endothelial Growth Factor ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Phase Iii ◽

Vascular Endothelial ◽

Medulläres Schilddrüsenkarzinom ◽

Epidermal Growth ◽

Endothelial Growth Factor

Vandetanib ist ein oraler Hemmer des RET-Kinase-, VEGF (Vascular Endothelial Growth Factor Receptor)- und EGFR (Epidermal Growth Factor Receptor)-Signalwegs. In einer zulassungsrelevanten, randomisierten, doppelblinden, placebokontrollierten Phase- III-Studie verlängerte der Tyrosinkinasehemmer das progressionsfreie Überleben (PFS) signifikant länger als Placebo.

Download Full-text

Expression des „Epidermal Growth-Factor Receptor“ (EGFR) und des „Vascular Endothelial Growth Factor“ (VEGF) bei Lymphangioleiomyomatose (LAM)

Pneumologie ◽

10.1055/s-2006-934022 ◽

2006 ◽

Vol 60 (S 1) ◽

Author(s):

H Watz ◽

K Engels ◽

M Amthor ◽

D Kirsten ◽

H Magnussen

Keyword(s):

Vascular Endothelial Growth Factor ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Epidermal Growth ◽

Endothelial Growth Factor

Download Full-text

Faculty Opinions recommendation of Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1163678.625451 ◽

2009 ◽

Author(s):

David Bates

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Lymphatic Vessel ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endogenous Inhibitor ◽

Vessel Growth ◽

Alternatively Spliced ◽

Endothelial Growth Factor

Download Full-text

Faculty Opinions recommendation of Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.11744956.12828054 ◽

2011 ◽

Author(s):

Asma Nusrat

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Receptor Antagonism ◽

Endothelial Growth Factor ◽

Α2β1 Integrin

Download Full-text

Faculty Opinions recommendation of Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.11744956.13740054 ◽

2011 ◽

Author(s):

Richard L Stevens

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Receptor Antagonism ◽

Endothelial Growth Factor ◽

Α2β1 Integrin

Download Full-text

Faculty Opinions recommendation of 111In-bevacizumab imaging of renal cell cancer and evaluation of neoadjuvant treatment with the vascular endothelial growth factor receptor inhibitor sorafenib.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717697854.793153053 ◽

2012 ◽

Author(s):

Hendrik van Poppel ◽

Yuri Tolkach

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Renal Cell Cancer ◽

Cell Cancer ◽

Neoadjuvant Treatment ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Endothelial Growth Factor ◽

Receptor Inhibitor

Download Full-text

Inhibition of the focal adhesion kinase and vascular endothelial growth factor receptor-3 interaction leads to decreased survival in human neuroblastoma cell lines

Molecular Carcinogenesis ◽

10.1002/mc.21969 ◽

2012 ◽

Vol 53 (3) ◽

pp. 230-242 ◽

Author(s):

Elizabeth A. Beierle ◽

Xiaojie Ma ◽

Jerry E. Stewart ◽

Michael Megison ◽

William G. Cance ◽

...

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Focal Adhesion ◽

Neuroblastoma Cell ◽

Growth Factor Receptor ◽

Human Neuroblastoma Cell ◽

Vascular Endothelial ◽

Human Neuroblastoma ◽

Endothelial Growth Factor ◽

Neuroblastoma Cell Lines

Download Full-text

Characterization and development of a peptide substrate-based phosphate transfer assay for the human vascular endothelial growth factor receptor-2 tyrosine kinase

Analytical Biochemistry ◽

10.1016/j.ab.2006.10.038 ◽

2007 ◽

Vol 360 (2) ◽

pp. 196-206 ◽

Author(s):

Genshi Zhao ◽

Robert B. Peery ◽

Jonathan M. Yingling

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Tyrosine Kinase ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Peptide Substrate ◽

Endothelial Growth Factor

Download Full-text